PPSG
ARNA

Princeton Portfolio Strategies Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,200
Closed -$246K – 112
2013
Q2 		$246K Buy
+3,200
New +$261K 0.2% 93

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Princeton Portfolio Strategies Group's ARNA Position: Q3 2013 in Review

Princeton Portfolio Strategies Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2013, closing a stake of 3,200 shares — an estimated $246K sold.

Princeton Portfolio Strategies Group first reported a position in ARNA in Q2 2013 and held it in 1 quarter. The position peaked at $246K in Q2 2013. 140 funds tracked by Wall St. Rank hold ARNA as of Q3 2013.

  • Princeton Portfolio Strategies Group reported no remaining Arena Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 3,200 Arena Pharmaceuticals Inc shares in Q3 2013, an estimated $246K.
  • Princeton Portfolio Strategies Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • Princeton Portfolio Strategies Group's Arena Pharmaceuticals Inc position peaked at $246K in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2013.

Based on Princeton Portfolio Strategies Group's 13F filing for Q3 2013, filed 13 Nov 2013.